Balance Of Rewards And Risks Could Be Changing

BMI View: The upsides of the Saudi Arabian pharmaceutical market are strong population demographics, high levels of chronic disease and increasing investment in social infrastructure. However, there are still persistent problems in the country's business environment that need addressing and short-term political risk in the region is currently very high. Currently, BMI does not expect the levels of disruption seen in Egypt and other Middle Eastern countries to spread to Saudi Arabia, though there have been some reports of unrest within the

To read the full article, please choose one of the following options: